Microbiology & Virology Market Research Reports & Industry Analysis
One of the main focuses in virology is the study of viral infectious diseases including: rhinoviruses (common cold), influenza (flu), Herpes (simplex, zoster and varicella-zoster), AIDS (autoimmune deficiency virus), Human Papillomavirus (HPV), rabies and measles.
Some viruses, known as oncoviruses, are known to be cancer causing. The most widely studied example is the link between HPV, a sexually transmitted virus, and cervical cancer.
There are more then 150 strains of HPV, over 40 of which are sexually transmitted. Certain types of “high-risk” sexually transmitted HPV viruses can lead to cell mutations and cause cervical cancer as well as cancer of the vagina, vulva, penis and anus. Research shows that these high-risk HPV viruses cause over 99% of cervical cancers.
According to the National Cancer Institute, it is estimated that in 2010 about 12,000 women in the United States were diagnosed with cervical cancer and more than 4000 would die from it.
Although there are no treatments available for HPV, the FDA approved Cervarix and Gardisil, vaccines used to protect against the types of HPV that most commonly cause cervical cancer.
Microbiology & Virology Industry Research & Market Reports
-
Spain In-vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... Covid-19 pandemic impacted the studied market significantly. During the initial phase of the pandemic due to the lockdowns and shutdowns, the market was impacted adversely. However, owing to the increasing demand for testing and diagnosis ... Read More
-
South Africa In-Vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... USD 880.5 million in 2027 with a CAGR of 6.93% during the forecast period, 2022-2027. The COVID-19 pandemic turned the spotlight on in-vitro diagnostics since there is an increasing demand for IVD kits and reagents ... Read More
-
Tuberculosis Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... had a significant impact on the healthcare systems, with significant consequences not only for COVID-19-infected patients but also for others, resulting in the cancellation of diagnosis and treatment services to manage and reserve resources, and ... Read More
-
Lyme Disease Diagnostic Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... pandemic has eclipsed the attention of healthcare professionals, affecting all areas of health and diagnostics care. The crisis has had several indirect health effects as well. People with Lyme disease symptoms were asked to postpone ... Read More
-
Anti-tuberculosis Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... pandemic had a significant impact on the healthcare systems, with significant consequences not only for COVID-19-infected patients but also for others, resulting in the cancellation of diagnosis and treatment services to manage and reserve resources, ... Read More
-
Saudi Arabia In-vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... initial days of the pandemic, the kingdom of Saudi Arabia was in lockdown and suspended trade with other countries, and implemented travel restrictions, which has led to a decline in medical diagnoses in the first ... Read More
-
Clinical Laboratory Services Market (Test Type: Clinical Chemistry, Medical Microbiology & Cytology, Food Intolerance Test, Human & Tumor Genetics, and Other Esoteric Tests) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Laboratory Services Market – Scope of Report TMR’s report on the global clinical laboratory services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators ... Read More
-
Global Toxoplasmosis Testing Market - 2022-2029
... during the forecast period (2022-2029). Toxoplasmosis is caused by infection with the protozoan Toxoplasma gondii, an obligate intracellular parasite. The infection produces a wide range of clinical syndromes in humans, land and sea mammals, and ... Read More
-
Global Tuberculosis Testing Market - 2022-2029
... of 6.0% during the forecast period (2022-2029). Tuberculosis (TB) is a communicable disease that is a major cause of ill health, one of the top 10 causes of death worldwide, and the leading cause of ... Read More
-
Global Cervical Cancer Treatment Market - 2022-2029
... cervix is the lower part of the uterus that connects to the vagina. Cervical cancer begins in the cells of the cervix. Most cervical malignancies are caused by strains of the sexually transmitted pathogen, Human ... Read More
-
Global Legionella Testing Market - 2022-2029
... pneumonia called Legionnaires disease or flu-like illness. Legionella testing aids in detecting the presence of bacteria to help diagnose the cause of a person's pneumonia. Market Dynamics The major driving forces are the rising incidence ... Read More
-
Global Clinical Microbiology Market - 2022-2029
... 6.5% during the forecast period (2022-2029). Clinical microbiology focuses on all aspects of patient infections from testing samples to identifying bacterial, viral, fungal, and parasitic agents that are contributing to the infectious process, determining the ... Read More
-
Mycobacterium Tuberculosis Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
... Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Mycobacterium Tuberculosis Tests pipeline products with comparative analysis of the products at various stages of development and information about ... Read More
-
Point-of-Care Diagnostics Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Product (Glucose Monitoring Products, Infectious Disease Testing Products) and Platform (Lateral Flow Assays, Immunoassays), 2022-2027
... at US$36.99 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.92% during 2022-2027. The point-of-care diagnostics market report provides an executive-level overview of the point-of-care diagnostics market ... Read More
-
Lab Automation For In-vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... forecast period. The rise in testing as a result of the pandemic can be attributed to the growth in in-vitro diagnostic adoption. The growth of the market is anticipated to be fueled by the creation ... Read More
-
Global Respiratory Infectious Disease Diagnostics Market - 2022-2029
... a CAGR of 1.8% during the forecast period (2022-2029). Respiratory infections are caused by virus, bacteria, and other microbes, which further infect the respiratory system including the lungs, throat, and airways. Spread of infections is ... Read More
-
Tuberculosis (TB) Diagnostics Market Forecasts to 2028 – Global Analysis by Product Types (Detection of Latent Infection, Cytokine Detection Assay, Diagnostic Laboratory Methods, Other Product Types), Test Type (Tuberculin skin tests, Interferon-gamma release assays (IGRAs), Smear microscopy, Other test types), Type (Sputum Smear Microscopy, Rapid Molecular Diagnostics, Other Types), End-user (Diagnostic Laboratories, Hospitals, Other end users), and By Geography
... Smear microscopy, Other test types), Type (Sputum Smear Microscopy, Rapid Molecular Diagnostics, Other Types), End-user (Diagnostic Laboratories, Hospitals, Other end users), and By Geography According to Stratistics MRC, the Global Tuberculosis (TB) Diagnostics Market is ... Read More
-
Global Infectious Disease In Vitro Diagnostics Market Size study & Forecast, by Product (Instruments, Reagents, Software), by Application (Respiratory Virus, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, HIV, Hepatitis, COVID-19, Others), by Technology (Immunoassay, Molecular Diagnostics, Others, Microbiology) and Regional Analysis, 2022-2029
... Diagnostics, Others, Microbiology) and Regional Analysis, 2022-2029 Global Infectious Disease In Vitro Diagnostics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more ... Read More
-
North America Immunodiagnostic Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays (Vitamin D Assay, HIV Detection, HIV Ag/Ab Combo Assay, and Others), Radioimmunoassays, and Others], Clinical Indication [Infectious Diseases (COVID-19, Lyme, Zika, Infection Management, TORCH, Tuberculosis, Treponema, Measles & Mumps, EBV, and VZV), Hepatitis+HIV, Gastrointestinal, Metabolics[PL1] , Endocrinology (Hypertension, GROWTH, Diabetes, Thyroid, and Reproductive Endocrinology), and Others], and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others) [PL2]
... Clinical Indication [Infectious Diseases (COVID-19, Lyme, Zika, Infection Management, TORCH, Tuberculosis, Treponema, Measles & Mumps, EBV, and VZV), Hepatitis+HIV, Gastrointestinal, Metabolics[PL1] , Endocrinology (Hypertension, GROWTH, Diabetes, Thyroid, and Reproductive Endocrinology), and Others], and End User ... Read More
-
Hepatitis E Diagnostic Tests Market By Test Type (ELISA HEV IgM Test, ELISA HEV IgG Test, RT-PCR Test), By End User (Hospitals, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... E diagnostic tests market was valued at $61.69 million in 2021, and is projected to reach $93.5 million by 2031, registering a CAGR of 4.2% from 2022 to 2031. Hepatitis E is a type of ... Read More
-
United States Market for In Vitro Diagnostic (IVD) Tests
... state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. This latest report from Kalorama Information, United States ... Read More
-
Global Hepatitis E Diagnostic Tests Market - 2022-2029
... a CAGR of 4.5 % during the forecast period (2022-2029). The hepatitis E virus causes the enteric liver disease known as hepatitis E. (HEV). It belongs to the group of five known human hepatitis viruses ... Read More
-
2022 Medical and Diagnostic Testing Global Market Size & Growth Report with Updated Forecasts
... with forecasts for 2022 and 2026. The historical data utilizes in-depth survey results from companies that sell medical and diagnostic testing combined with country and regional economic, firmographic, and demographic data. Our analysts develop the ... Read More
-
Veterinary Tuberculosis Vaccine Market, by Type (Live Attenuated, Inactivated), by Route of Administration (Sub-cutaneous, Intramuscular, Oral), by Animal Type (Cattle, Dogs, Cats, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Tuberculosis (TB) is considered a reemerging, infectious granulomatous disease in animals and people caused by acid-fast bacilli of the genus Mycobacterium. Although commonly ... Read More
-
Point of Care Diagnostics Market Analysis and Forecast to 2031: By Product (Glucose Monitoring, Cardiometabolic Testing, Infectious Disease Testing, Blood Gas/Electrolytes Testing, Pregnancy & Fertility Testing, Tumor/Cancer Marker Testing), By Technology (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays), By Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse (DoA) Testing), By End-use (Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings), and Region
... Microfluidics, Molecular Diagnostics, Immunoassays), By Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse (DoA) Testing), By End-use (Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings), and Region The global point of care diagnostics market ... Read More
Research Assistance
